A new test may spur advances in drug discovery for a rare and debilitating neurological disorder. Charcot-Marie-Tooth disease, a rare inherited neurological disorder, affects more than 2.8 million people around the globe.
By Emily Leclerc, Waisman Science Writer The month of October is Down Syndrome Awareness Month and is dedicated to not only raising awareness about Down syndrome but also to celebrating the abilities and accomplishments of …
Could Alzheimer’s disease and schizophrenia be biologically connected?
Sousa is the second hire in the cluster initiative that includes a biostatistician, a neuroscientist, and a geneticist.
Pelin Cengiz, MD, an associate professor in the Department of Pediatrics and a Waisman Center investigator, is among this year’s recipients. She received the Chancellor’s Award for Excellence in Research: Independent Investigator.
The Biden administration’s loosening of restrictions on the use of fetal tissue in research will allow UW-Madison scientists to continue such studies, which opponents have tried several times to ban in Wisconsin.
A new study from the lab of UW-Madison professor of medicine Luigi Puglielli, MD, PhD, opens a door to potential treatments for diseases of age, such as Alzheimer’s disease, by defining the roles of two enzymes that are imperative to protein production.
Dr. Seth Pollak, the College of Letters & Science Distinguished Professor of Psychology, has been named a Fellow of the John Simon Guggenheim Memorial Foundation.
An analysis of electronic health records for 1.7 million Wisconsin patients revealed a variety of health problems newly associated with fragile X syndrome.
By Peter Jurich, Waisman Science Writer With every challenge comes new opportunities. When the COVID-19 pandemic hit the U.S. in March 2020, much of the country went on lock-down with only essential services and operations …